 |
市場調査レポート
商品コード
1287616
抗毒素市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 抗毒素市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
|
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
市場概要：
世界の抗毒素市場規模は、2022年に10億9,610万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.7%の成長率（CAGR）を示し、2028年までに16億4,490万米ドルに達すると予測しています。
抗毒素は、蛇毒が組織に結合し、重度のアレルギー反応、血液凝固、筋肉損傷、神経系障害を引き起こすのを阻止するために使用される精製抗体です。抗毒素は、ヘビに刺されたときに起こる毒の作用を抑制し、死亡率や病的状態を最小限に抑えることができます。ヘビ、フナクイムシ、オニグモ、アカグモ、ハコクラゲなど、さまざまな動物種から、さまざまな技術で入手されます。現在、一般的に使用される抗毒素の種類は、患者の病歴や検査、地理的、臨床的、病理的要因によって異なります。
抗毒素の市場動向：
ヘビ刺されの危険性は、特に農村部の人々が日常的に経験する公衆衛生上の危険です。農作業や狩猟をする人たちの職業病ともなっており、安全で効果的、かつ手頃な価格の抗毒素の必要性を高める重要な要因の一つとなっています。また、熱帯地方で一般的なオープンプランの住宅や床で寝る習慣は、夜行性の猛毒ヘビに咬まれる可能性があり、深刻な健康被害を引き起こすことがあります。これらの健康問題は通常、腎不全、呼吸を妨げる重度の麻痺、致命的な出血につながる出血障害、後遺症を引き起こし四肢切断に至る重度の局所組織破壊などです。このことが、世界中の抗毒素の需要を喚起しています。これとは別に、咬傷部位、尿、血漿、血液、その他の組織や体液のサンプルからヘビ毒を試験管内で検出し、免疫学的に同定するための迅速酵素免疫測定法を備えたヘビ毒検出キットが導入されています。これは、業界関係者に有利な成長機会を提供し、市場全体を牽引すると予想されます。
本レポートで回答した主な質問
- 2022年の世界の抗毒素市場の規模は？
- 2023年～2028年の世界の抗毒素市場の成長率はどのくらいと予想されるか？
- COVID-19が世界の抗毒素市場に与えた影響とは？
- 世界の抗毒素市場を牽引する主要因は何か？
- 種族に基づく世界の抗毒素市場の内訳は？
- 抗毒素の種類に基づく世界の抗毒素市場の内訳は？
- 抗毒素の世界市場の作用機序に基づくブレークアップは？
- エンドユーザーに基づく世界の抗毒素市場の内訳は？
- 世界の抗毒素市場における主要地域は？
- 世界の抗毒素市場における主要企業は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査目的
- 利害関係者
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 予測手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要産業動向
第5章 世界の抗毒素市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 種族別市場内訳
- 蛇
- 市場動向
- 市場予測
- さそり
- 市場動向
- 市場予測
- 蜘蛛
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第7章 駆除薬タイプ別市場内訳
- 多価抗毒剤
- 市場動向
- 市場予測
- 一価抗毒剤
- 市場動向
- 市場予測
第8章 作用機序別市場内訳
- 細胞毒性
- 市場動向
- 市場予測
- 神経毒性
- 市場動向
- 市場予測
- 血毒性
- 市場動向
- 市場予測
- 心臓毒性
- 市場動向
- 市場予測
- 筋毒性
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第9章 エンドユーザー別市場内訳
- 病院
- 市場動向
- 市場予測
- 診療所
- 市場動向
- 市場予測
- 外来手術センター
- 市場動向
- 市場予測
第10章 地域別市場内訳
- 北米
- 米国
- 市場動向
- 市場予測
- カナダ
- 市場動向
- 市場予測
- 米国
- アジア太平洋地域
- 中国
- 市場動向
- 市場予測
- 日本
- 市場動向
- 市場予測
- インド
- 市場動向
- 市場予測
- 韓国
- 市場動向
- 市場予測
- オーストラリア
- 市場動向
- 市場予測
- インドネシア
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- 中国
- 欧州
- ドイツ
- 市場動向
- 市場予測
- フランス
- 市場動向
- 市場予測
- 英国
- 市場動向
- 市場予測
- イタリア
- 市場動向
- 市場予測
- スペイン
- 市場動向
- 市場予測
- ロシア
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- ドイツ
- ラテンアメリカ
- ブラジル
- 市場動向
- 市場予測
- メキシコ
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- ブラジル
- 中東・アフリカ地域
- 市場動向
- 国別市場内訳
- 市場展望
第11章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第12章 バリューチェーン分析
第13章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の度合い
- 新規参入業者の脅威
- 代替品の脅威
第14章 価格分析
第15章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Bharat Serums and Vaccines Limited（BSV）
- Boehringer Ingelheim International GmbH
- Boston Scientific Corporation
- CSL Limited
- Haffkine Bio-Pharmaceutical Corporation Limited
- Incepta Pharmaceuticals Limited
- Merck & Co. Inc.
- Merck KGaA
- MicroPharm Limited
- Pfizer Inc.
- Rare Disease Therapeutics Inc.
図表
List of Figures
- Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
- Figure 2: Global: Anti-venom Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2022
- Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2022
- Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2022
- Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2022
- Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2022
- Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: North America: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: United States: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Canada: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: China: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Japan: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: India: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: South Korea: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Australia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Europe: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Germany: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: France: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Italy: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Spain: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Russia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Latin America: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Brazil: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Mexico: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
- Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2022
- Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 88: Global: Anti-venom Industry: SWOT Analysis
- Figure 89: Global: Anti-venom Industry: Value Chain Analysis
- Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anti-venom Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million US$), 2023-2028
- Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million US$), 2023-2028
- Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million US$), 2023-2028
- Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Anti-venom Market: Competitive Structure
- Table 8: Global: Anti-venom Market: Key Players
目次
Product Code: SR1623A374_Report
Market Overview:
The global anti-venom market size reached US$ 1,096.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,644.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
Anti-venoms are purified antibodies used to stop snake venom from binding to tissues and causing severe allergic reactions, blood-clotting, muscle injury, or nervous system problems. They can prevent or reverse the snakebite envenoming effects, which help minimize mortality and morbidity. They are obtained from different animal species, such as snakes, funnel web spiders, stonefish, redback spiders, and box jellyfish, using different technologies. Presently, the type of anti-venom generally used depends on the history and examination of the patient and geographic, clinical, and pathologic factors.
Anti-Venom Market Trends:
The risk of snakebite envenoming is a public health hazard that people, especially in the rural areas, experience on a regular basis. It causes occupational injury among several agricultural workers and hunters, which represents one of the key factors driving the need for safe, effective, and affordable anti-venoms. In addition, open-plan housing and the practice of sleeping on the floor, common in tropical regions, can expose people to bites from nocturnal and highly venomous snakes and cause serious health problems. These health problems usually include kidney failure, severe paralysis that prevents breathing, bleeding disorders that can lead to fatal hemorrhage, and severe local tissue destruction that can cause permanent disability and result in limb amputation. This, in turn, is catalyzing the demand for anti-venoms across the globe. Apart from this, there is an introduction of snake venom detection kits with a rapid enzyme immunoassay for in vitro detection and immunological identification of snake venom in samples from bite sites, urine, plasma, blood, or other tissues and body fluids. This is anticipated to offer lucrative growth opportunities to industry players and drive the overall market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-venom market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on species, anti-venom type, mode of action and end user.
Breakup by Species:
- Snake
- Scorpion
- Spider
- Others
Breakup by Anti-venom Type:
- Polyvalent Anti-venom
- Monovalent Anti-venom
Breakup by Mode of Action:
- Cytotoxic
- Neurotoxic
- Haemotoxic
- Cardiotoxic
- Myotoxic
- Others
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc. and Rare Disease Therapeutics Inc.
Key Questions Answered in This Report:
- What was the size of the global anti-venom market in 2022?
- What is the expected growth rate of the global anti-venom market during 2023-2028?
- What has been the impact of COVID-19 on the global anti-venom market?
- What are the key factors driving the global anti-venom market?
- What is the breakup of the global anti-venom market based on the species?
- What is the breakup of the global anti-venom market based on the anti-venom type?
- What is the breakup of the global anti-venom market based on the mode of action?
- What is the breakup of the global anti-venom market based on the end user?
- What are the key regions in the global anti-venom market?
- Who are the key players/companies in the global anti-venom market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-venom Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Species
- 6.1 Snake
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Scorpion
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Spider
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Anti-venom Type
- 7.1 Polyvalent Anti-venom
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Monovalent Anti-venom
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Mode of Action
- 8.1 Cytotoxic
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Neurotoxic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Haemotoxic
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Cardiotoxic
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Myotoxic
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Boehringer Ingelheim International GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Boston Scientific Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 CSL Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Incepta Pharmaceuticals Limited
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck & Co. Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck KGaA
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 MicroPharm Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Rare Disease Therapeutics Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.1 Bharat Serums and Vaccines Limited (BSV)
